date:Apr 04, 2019
r 15 days. At the end of this period, in the next 5 days, a daily dose of LPS was administered. The LPS is a component of the bacterial wall that induces a specific inflammation in the intestine. At the end of the treatment, blood and intestine samples were taken and it was possible to observe that both dosages, nutritional and pharmacological, had protected the intestine from the damage induced by LPS, modulating in a positive way the expression of genes involved in the anti-inflammatory respon